Product/Composition:- | Tenofovir Disoproxil Fumarate(TDF) tablets |
---|---|
Strength:- | 300 mg |
Form:- | Oral tablets |
Reference Brands:- | Viread® (EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Tenofovir Disoproxil Fumarate (TDF) is a 300 mg oral antiviral used to treat chronic Hepatitis B and HIV-1 infections. It inhibits viral reverse transcriptase, reducing viral replication and disease progression. Marketed as Viread®, it is approved by FDA and EMA and widely used in the US and EU. TDF is a key drug for pharma B2B suppliers and healthcare professionals managing viral infections.
Tenofovir Disoproxil Fumarate (TDF) is a potent nucleotide reverse transcriptase inhibitor used to treat chronic Hepatitis B virus (HBV) infection and HIV-1. Available as oral tablets at 300 mg strength, TDF effectively blocks viral replication by inhibiting viral reverse transcriptase enzymes, reducing viral load and preventing disease progression. Marketed under the brand name Viread® by Gilead Sciences, it is approved by the US FDA and EMA. Widely prescribed in both the EU and US, Tenofovir Disoproxil Fumarate is essential for pharma B2B suppliers and healthcare providers managing viral hepatitis and HIV therapies.